Work

A phase II, multicenter, open-label study of lifileucel (tumor-infiltrating lymphocytes) in participants with previously treated advanced endometrial cancer

Year: 2025

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2025.04.126

Authors: Kathleen Moore, Amir Jazaeri, Koji Matsuo, Emese Zsiros, Jason Chesney, John Nakayama, Akiko Suzuki, Anjali Desai, Siyu Zhu, Brian Gastman, Jeffrey Chou, Friedrich Graf Finckenstein

Institutions: OU Health Stephenson Cancer Center, University of Oklahoma, The University of Texas MD Anderson Cancer Center, University of Southern California, Roswell Park Comprehensive Cancer Center, University of Louisville, Allegheny Health Network, Iovance Biotherapeutics (United States)

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4414649484

FWCI:

Cites:

Cited by:

Related to: